September 14, 7:15 AM
Mizuho analyst Mara Goldstein downgrades Kadmon Holdings (NASDAQ:KDMN) from Buy to Neutral and lowers the price target from $13 to $9.5.
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
September 12, 4:04 PM
Biotech stocks retreated in the holiday-shortened week ending Sept. 10, reversing course from the previous week.
September 9, 8:35 AM
Telsey Advisory Group lifted the price target on Lululemon Athletica Inc. (NASDAQ: LULU) from $460 to $485. Lululemon shares surged 13.9% to $433.58 in pre-market trading.
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi’s Pemphigus Trial Disappointment, Humanigen’s COVID-19 Drug Denied Emergency Use Authorization
September 9, 8:17 AM
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8)
September 8, 2:32 PM
Toward the end of trading Wednesday, the Dow traded down 0.24% to 35,015.62 while the NASDAQ fell 0.61% to 15,280.10. The S&P also fell, dropping 0.20% to 4,510.78.